Placeholder Banner

BIO President: Executive Order on Agricultural Biotechnology Is ‘Important Step Forward’

The Biotechnology Innovation Organization (BIO) today expressed support for President Donald J. Trump’s executive order, titled “Modernizing the Regulatory Framework for Agricultural Biotechnology Products.” 

June 11, 2019
Media Contact
Connor McKoy
202.312.9288

Washington, D.C. (June 11, 2019) – The Biotechnology Innovation Organization (BIO) today expressed support for President Donald J. Trump’s executive order, titled “Modernizing the Regulatory Framework for Agricultural Biotechnology Products.” The executive order (EO 13874) directs the U.S. Food and Drug Administration, U.S. Department of Agriculture, and U.S. Environmental Protection Agency to review their respective agricultural biotechnology regulatory systems in an effort to streamline processes and remove overly burdensome regulations.

The following statement may be attributed to BIO President and CEO Jim Greenwood:

“America is on the threshold of entering a new era of sustainable agriculture and food production, and it’s important we get this right for farmers, consumers, U.S. companies, and the world as a whole. With prudent regulations, we can foster American innovation and bring to market biology-driven solutions that are improving nutrition, reducing food waste, increasing crop yield, combating debilitating crop diseases, and advancing environmentally friendly farming practices.

“BIO applauds the Trump administration for taking this important step forward to ensure government policy does not hinder 21st-century biotechnology from addressing the many global challenges—from a looming food crisis to climate change—facing society today. We will continue to engage with the agencies throughout this process to ensure our regulatory infrastructure is science-based and transparent, and just as we are committed to working with the government, we also pledge to be a driver of forthright conversations and dialogues with consumers in an effort to identify shared values and energize public understanding.”

###

Discover More
“What has set the U.S. biotech sector apart has been thoughtful, bipartisan public policy approaches that create a favorable climate in which to undertake the lengthy and risky job of investing in and developing the next biotech breakthroughs.”
Washington, D.C. (August 10, 2019) –The Biotechnology Innovation Organization (BIO) released the following statement on the administration’s decision to issue 31 small refinery exemptions under the Renewable Fuel Standard. “The administration…
The Biotechnology Innovation Organization (BIO) today put forward a consumer-friendly proposal that would improve public access to information about new agricultural biotechnology products. Combined with a new science-based regulatory approach, BIO…